IPAD-DB ID | C00071 |
Name | Nordihydroguaiaretic acid |
Category | Natural compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 8 H 2 2 O 4 |
Molecular Weight | 302.4g/mol |
IUPAC Name | 4-[4-(3, 4-dihydroxyphenyl)-2, 3-dimethylbutyl]benzene-1, 2-diol |
InChI | InChI=1S/C18H22O4/c1-11(7-13-3-5-15(19)17(21)9-13)12(2)8-14-4-6-16(20)18(22)10-14/h3-6, 9-12, 19-22H, 7-8H2, 1-2H3 |
InChIKey | HCZKYJDFEPMADG-UHFFFAOYSA-N |
Canonical SMILES | CC(CC1=CC(=C(C=C1)O)O)C(C)CC2=CC(=C(C=C2)O)O |
PubChem CID | 4534 |
DrugBank Accession Number | - |
CAS Registry Number | 500-38-9 |
Molecular Weight(Computed by SwissADME) | 302.36 |
Hac(Computed by SwissADME) | 22 |
Volume(Computed by ADMETlab 2.0) | 322.113 |
Density(Computed by ADMETlab 2.0) | 0.938 |
nRing(Computed by ADMETlab 2.0) | 2 |
MaxRing(Computed by ADMETlab 2.0) | 2 |
nHet(Computed by ADMETlab 2.0) | 4 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 12 |
Flexibility(Computed by ADMETlab 2.0) | 0.417 |
Stero Centers(Computed by ADMETlab 2.0) | 2 |
LogS(Computed by ADMETlab 2.0) | -3.172 |
LogD(Computed by ADMETlab 2.0) | 3.588 |
logP(Computed by ADMETlab 2.0) | 3.441 |
TPSA(Computed by SwissADME) | 80.92 |
Hbond Acceptor(Computed by SwissADME) | 4 |
Hbond Donor(Computed by SwissADME) | 4 |
Rotatable Bonds(Computed by SwissADME) | 5 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | Yes |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | Yes |
CYP2D6 Inhibitor(Computed by SwissADME) | Yes |
CYP3A4 Inhibitor(Computed by SwissADME) | Yes |
log Kp(Skin Permeation)(Computed by SwissADME) | -5.08 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.55 |